MecRx mecrx.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

MecRx is an early stage drug development company working on new treatments for cancer. Using proprietary 'hit identification' technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50 per cent of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Institute and CSIRO and is headquartered in Melbourne, Australia.

MecRx is an early stage drug development company working on new treatments for cancer. Using proprietary 'hit identification' technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50 per cent of all human cancers. ...Show all

Company (Alive / Active)

Phone:

Fax:

Level 9
278 Collins St
Melbourne, 3000
Victoria, Australia

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MecRx $4M Mar 23, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MecRx Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Brandon Capital PartnersVenture CapitalMelbourne, Victoria, AustraliaSeries A
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)